🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › New York › Queens

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Queens, NY

49 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Queens (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04267848

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Mengambil pesertaFasa 3
  • New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06472245

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07293247

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

Mengambil pesertaFasa 2/3
  • NYU Langone Hospital Long Island, Mineola · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07365319

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • START New York Long Island LLC, Lake Success · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06270706

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Mengambil pesertaFasa 3
  • Optum Medical Care, PC, Westbury · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07361497

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Mengambil pesertaFasa 3
  • Local Institution - 0224, Laurelton · 5 mi jauh
  • Optum Medical Care, PC, Westbury · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07361510

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Mengambil pesertaFasa 3
  • Optum Medical Care, PC, Westbury · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06765109

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 2
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06667076

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Research Site, Fresh Meadows · 4 mi jauh
  • Research Site, Westbury · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06868277

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 2
  • Clinical Research Alliance - Westbury /ID# 270455, Westbury · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06568939

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Mengambil pesertaFasa 1/2
  • START New York, Lake Success · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07488676

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Mengambil pesertaFasa 2/3
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07100080

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 3
  • Research Site, Westbury · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06692738

A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 1
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07619339

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07323732

Using Urine Samples to Identify Lung Cancer

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
Umur 18 hingga 90 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06033248

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT04410796

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

Mengambil pesertaFasa 1
  • Site 107 - START New York - Long Island, Lake Success · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07462377

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi jauh
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • START NY Long Island, Lake Success · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07361562

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Mengambil pesertaFasa 1
  • NYU Langone Health - Long Island, Mineola · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06400472

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

Mengambil pesertaFasa 1/2
  • START New York Long Island, New Hyde Park · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07287995

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Mengambil peserta
  • Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05837767

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Mengambil pesertaFasa 1
  • Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05245500

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Mengambil pesertaFasa 3
  • NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06500481

A Study of MGC026 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • START-New York Long Island, Lake Success · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06242470

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT01639508

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Mengambil pesertaFasa 1/2
  • Northwell Health, Lake Success · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Jul 2026 · NCT05098132

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Mengambil pesertaFasa 3
  • Queens Cancer Center, Rego Park · 3 mi jauh
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT06686771

A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT07535437

Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer

Mengambil pesertaKajian pemerhatian
  • Memorial Sloan Kettering Nassau (Consent Only), Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05424029

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · 9 mi jauh
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · 27 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04389632

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Mengambil pesertaFasa 1/2
  • Clinical Research Alliance, Westbury · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jun 2026 · NCT06162221

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Mengambil pesertaFasa 3
  • New York Cancer & Blood Specialists (NYCBS), New Hyde Park · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT06216301

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Mengambil pesertaFasa 1
  • START New York Long Island, LLC, Lake Success · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Jun 2026 · NCT07503808

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • START New York Long Island, LLC, Lake Success · 9 mi jauh
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Jun 2026 · NCT07540572

A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT07594522

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Mei 2026 · NCT05657873

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Apr 2026 · NCT07535463

Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Mac 2026 · NCT07218601

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Queens Hospital Center, Jamaica · 2 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Feb 2026 · NCT03808337

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Feb 2026 · NCT07428044

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Hempstead · 12 mi jauh
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Queens

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.